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Abstract—Hospital At Home (HAH) is a concept slowly expanding over 
time. At first this type of organization was used to accomplish low-
technical tasks. The main objective was to increase bed availability in 
hospitals for new patients. Nowadays, HAH structures are able to 
undertake more technical complex care such as (but not limited to) end-
of-life care, chemotherapy and rehabilitation. This article accomplishes 
two main objectives: (i) in the first part we propose a comprehensive 
literature review dealing with the comparison between traditional 
hospital and home care structures from an economic standpoint, showing 
that results are highly dependent on initial conditions of the study 
(patient health state, territory settings, bio-medical parameters); (ii) in 
the second part we propose an unbiased economic comparison approach 
between health care provided in traditional hospital and home care 
network using formal modeling with Petri nets and discrete event 
simulation. As an example for the comparison a multi-session treatment 
is proposed. Various scenarios are tested to ensure that results will be 
maintained even if initial conditions change. Relevant performance 
indicators used for comparison are economic costs from the point of view 
of the insurance and economic costs related to the consumption of 
resources. This work was founded by the Rhône-Alpes region in France 
as a part of OSAD project.

Keywords- HAD, HAH, Hospital at Home, Cost comparison  
studies, Simulation.  
I.  INTRODUCTION 
Hospital At Home (HAH) is often presented as an important 
organization of health care in developed countries. This 
alternative is interesting for several reasons, such as expanding 
the coverage of rural regions and increasing patient 
satisfaction. The economic stake is to maximize the benefit of 
these advantages avoiding drastic costs increase. Comparing 
HAH with traditional hospitalization can provide useful 
information to healthcare authorities when deciding to create 
or not new HAH structures.  
Experiences of hospitalization at home are not so numerous. 
Technical care (such as chemotherapy, blood transfusion, 
rehabilitation…), once devoted to hospital, might now be 
dispensed at home, but experiences remained local and 
isolated. The first step of any study is the feasibility at home in 
terms of bio-medical impact and security of care. We postulate 
that authorities will not allow healthcare to be done at home if 
there is a medical risk for the patient. Then the question of 
motivation for home care will be related to the cost of 
allocated resources and to patient perspective, including 
quality of life, access to care when hospital is far from their 
home, and other satisfaction criteria. For the cost and 
resources perspective, technical difficulties exist. The first one 
is the perspective chosen when we calculate costs: what are 
the costs that will be included? Who is charged with these 
costs? How these costs will be calculated? Is it long term or 
short term costs? The result is highly sensitive to these 
questions and the same situation could lead to different 
conclusions when different costs are evaluated. 
In this paper, we propose a new methodology to make an 
unbiased economic comparison between HAH structures and 
traditional hospitalization. To do so, a generic multisession 
treatment is modeled using Petri nets, taking into account bio-
medical parameters and patient health status using the 
Karnofsky score. Discrete event simulation is then used to 
assess the model validity and perform a sensivity analysis to 
evaluate the impact of initial conditions on the results. Finally, 
various simulation scenarios are established to conclude about 
the economic pertinence of HAH structures 
The remaining of this paper is organized as follow. A 
comprehensive literature review on HAH versus traditional 
hospitalization comparison is presented in Section II. The 
strategy to establish an unbiased comparison between HAH 
and traditional hospitalization from an economical point of 
view is presented in Section III. A formal model using Petri 
nets is presented in Section IV. Data collection and analysis is 
described in Section V. The simulation study is detailed in 
Section VI along this the sensivity analysis of initial 
parameters, simulation scenarios and results. Finally, 
conclusions and perspectives are proposed in Section VII. 
II. LITERATURE REVIEW 
A comprehensive literature review is presented in order to 
understand the added value of HAH structures compared to 
traditional hospitalization under various conditions. All 
  
articles presented in this literature review were published in 
the nineties and later, implying that home health-care 
organizations became a fundamental actor in the health-care 
landscape during the last decade in developed countries. The 
question about its pertinence and its cost-effectiveness is 
recent. 
The research was conducted in various databases from the 
nineties to nowadays, including (but not limited to) the 
National Library of Medicine (of the National Institutes of 
Health, USA), the Cochrane database, the PubMed database, 
the Centre for Reviews and Dissemination (of the National 
Institute for Health Research, UK), the National Guideline 
Clearinghouse (USA), the European health for all database (of 
the World Health Organization, Regional Office for Europe) 
and the Institute of Health Economics (Canada) for the 
English-speaking bibliography. The bibliographic research 
strategy is presented in Table 1. 
 
TABLE 1  
 
The literature review is divided in three sections depending on 
the perspective used for the comparison between HAH and 
traditional hospitalization: bio-medical perspective, patient 
satisfaction, and economic stake. 
 
Bio-medical perspective 
 
Some studies show an equivalence or advantage of HAH from 
the bio-medical perspective for several medical treatments: 
colorectal cancer chemotherapy (Borras et al. 2001), perinatal 
services (Goulet et al. 2001), multiple sclerosis treatment 
(Chataway et al. 2006), dementia treatment (Tibaldi et al. 
2004), non-massive pulmonary embolism and acute 
respiratory disease (Rodriguez-Cerrillo et al. 2009), hip 
replacement, hysterectomy, elder illness and respiratory 
obstructions (Shepperd & Iliffe 1998), chronic obstructive 
pulmonary disease (COPD) (B. Leff et al. 2005; Shepperd et 
al. 2009), cellulites (B. Leff et al. 2005; Shepperd et al. 2009), 
and others illnesses needing acute care (Shepperd et al. 2009), 
cardiac rehabilitation (B. Leff et al. 2005; Shepperd et al. 
2009; Richards et al. 1998; Hermiz et al. 2002), community-
acquired pneumonia (B. Leff et al. 2005; Shepperd et al. 
2009). HAH is also an effective healthcare provider for elder 
patients requiring acute care and suitable for early discharge 
(Richards et al. 1998; Hermiz et al. 2002; Bruce Leff et al. 
2009; Bruce Leff et al. 2008) and for behavioral disturbances 
such as agitation, aggressiveness, feeding and sleeping 
disorders (Tibaldi et al. 2004). 
 
Patient satisfaction 
 
Patients at home satisfaction was also studied in various 
studies: satisfaction is generally higher compared to traditional 
hospitalization (Borras et al. 2001; Goulet et al. 2001; 
Richards et al. 1998; Hermiz et al. 2002; R. S. Taylor et al. 
2007; Shepperd et al. 1998) but not in the case were the bio-
medical output was not adequate (Shepperd et al. 2009). It 
also has been proven that patients who already had a care 
episode at home are more favorable to HAH than traditional 
hospitalization (Rischin et al. 2000; Barcala et al. 2006). 
 
Economic stake 
 
As said before, there is an economic stake by introducing 
HAH in the healthcare system. Some studies compare both 
alternatives with different economic criteria founding that 
HAH can have economic advantages over traditional 
hospitalization (Borras et al. 2001; Chataway et al. 2006; B. 
Leff et al. 2005; Carrère et al. 2008; Remonnay et al. 2005). 
In these studies, it has been proven that the use of additional 
resources was not significant. A very important issue when 
comparing structures with economic criteria is the nature of 
the cost studied and who is paying for them. 
From the insurance point of view, HAH is interesting in some 
studies (Chataway et al. 2006; B. Leff et al. 2005; Barcala et 
al. 2006; H. Anderson et al. 2003; Oterino-de-la-Fuente et al. 
1998; Launois & Perrocheau 1996; Coast et al. 1998; 
Vergnenègre et al. 2006; Frick et al. 2009; C. Anderson et al. 
2000). In some cases the economic pertinence of HAH 
compared to traditional hospitalization depends on patients’ 
health status and disease gravity (Borras et al. 2001; Goulet et 
al. 2001). Contradictory evidence was found in (Shepperd & 
Iliffe 1998), (Frick et al. 2009) for COPD. For the same 
authors differences in points of view and cost analyzed make 
impossible to conclude which is the best structure (Shepperd 
et al. 2009). 
From hospital perspective, HAH delivery of healthcare 
services can be more expensive (Rischin et al. 2000). In 
particular, medicines are less expensive when managed 
directly in a hospital pharmacy (Launois & Perrocheau 1996). 
This problem can be solved if the HAH structure works 
directly with a hospital pharmacy. 
Finally, it is difficult to conclude about the economic 
pertinence of HAH compared to traditional hospitalization: 
- From the insurance point of view, HAH organization 
can produce savings for definite illnesses, especially 
for those with long treatment but where the care is 
punctual, like end-of-life care and rehabilitation 
issues.  
- HAH can produce the same bio-medical outcome 
quality with fewer resources. However, such 
economic benefit has not been proven on the long 
term, especially taking into account long multisession 
treatments. Additional factors may impact the 
economic viability of HAH structures, such as social 
and epidemiological parameters, or drastic changes in 
health policies that can occur. 
- Results are highly dependent on the initial conditions 
of the study: geographical distribution of patients, 
health status of patients, or resources to take into 
account.  
- Patient health status impact on economic pertinence 
of HAH is unclear: high cost variation may occur 
when long term illnesses are treated.  
  
Economic comparisons using traditional approaches are 
difficult to perform when introducing a new pricing scale for 
activities, materials or medicaments. Difficulties to calculate 
costs in reality tend to prove that the question about the most 
efficient structure cannot be answered in absolute terms but in 
some conditions-dependent terms. 
The proposed literature review is summarized in Tables 2 and 
3. In Table 2, articles comparing home-based hospitalization 
and traditional hospitalization with non-economic criteria are 
presented, including results of the comparison 
(advantage/disadvantage for each), type of study and used 
criteria. Table 3 present results of the comparison with 
economic criteria (illness, amount of patients, costs taken into 
account, stakeholder). 
 
TABLE 2 
 
TABLE 3 
 
Finally, in Table 4, the research articles are classified 
regarding to illness and criteria (bio-medical impact, quality of 
life, patient preferences, caregiver stress, costs). 
 
TABLE 4 
 
III. MAKING A UNBIASED COMPARAISON BETWEEN 
HOSPITAL AT HOME AND TRADITIONAL HOSPITALIZATION 
  
Position of the problem  
 
The literature review proves that comparisons between 
hospital at home and traditional hospitals is well assessed from 
a clinical point of view. However, economic comparisons are 
lacking, implying additional investigation. Therefore the 
question about unbiased comparisons is approached in this 
article using a formal simulation model as well as a sensivity 
analysis of initial parameters.  
To do so, we chose to describe a generic multisession 
treatment, which requires various care episodes for patients 
(such as chemotherapy and blood transfusion for 
Myelodysplastic syndrome). The proposed model must be 
generic enough to be applied to a wide range of care. In this 
case, a treatment is made of a certain number of sessions 
following a therapeutic plan. 
As shown before, comparisons from an economic standpoint 
are difficult to undertake for three reasons: 
1. Point of view: Costs and resource consumptions vary 
depending on the actor. Hospital point of view is 
often used for cost calculation in the literature 
(Lanois & Perrocheau 1996, Rischin et al. 2000, 
Oterino-de-la-Fuente et al. 1998 and Shepperd et al. 
1998). Studies from the hospital standpoint can only 
be used to adjust organizational strategies of hospitals 
and not healthcare system policies. To develop these 
policies, society perspective should be preferred 
because of its higher standpoint; moreover, changes 
in actor’s behaviors and resource consumption in the 
whole system should be studied. 
2. Costs of resources: It can be useful to compare 
structures using resource consumption along with 
costs. In this case, time horizon must be taken into 
account (especially in the case of multisession 
treatments where resources costs can vary) in order to 
provide an unbiased comparison. 
3. Assignment of patients to structures: HAH structures 
and hospitals have different advantages. A structure 
may be able to provide care for certain illnesses with 
a lower cost. Thus comparing hospitals and home-
based structures without taking into account 
treatment characteristics and patients assignments can 
result in a bias for the study. For example, it may be 
interesting to define different rules to assign patients 
to HAH structures by using precise parameters such 
as distance from home to hospital or patient health 
status. 
In order to perform an unbiased comparison between HAH 
and traditional hospitalization, we propose a new strategy 
taking into account the aforementioned remarks. A formal 
modeling using Petri nets (Proth & Xie 1995) is proposed to 
describe a generic multisession treatment that could be 
undertaken by HAH structures or hospitals indifferently. A 
discrete-event simulation model is also proposed to test 
various bio-medical and organizational scenarios. Discrete-
event simulation (DES) is an useful tool to compare different 
structures without bias, as it will be explained later. This tool 
has proven to be a successful in healthcare optimization 
problems(Buthion et al. 2010) and especially for multi-session 
treatments simulation (Santibanez et al. 2009) like the 
reduction of waiting times (Sepúlveda et al. 1999); 
improvement of patients flow (Baesler & Sepúlveda 2002) and 
planning of activities (Werker et al. 2009), increase capacity 
(Eldabi et al. 1999) or as a decision aid tool (Angelis et al. 
2003). 
 
Assumptions The following assumptions are taken into 
account: 
1. The point of view of the society is preferred, even if 
impacts of policies on hospitals are important. 
2. Main performance indicators are (i) use of resources 
(cost of human and material resources) and overall 
costs, that are detailed below. 
 Treatment characteristics are defined for all patients, 
as well as the structure assignment decision taking 
into account biomedical parameters.
IV. MULTISESSION TREATMENT MODELLING 
 
 
Patient health status modeling 
 
  
Patient’s health status is the most important setting of the 
model considering bio-medical parameters because it 
determines in a multisession treatment (i) the number of 
session of each protocol, (ii) the length of sessions, and (iii) it 
can be used to implement a selection rule (treatment at home 
or in the hospital). In order to model patient’s health status, we 
choose the Karnofsky Score, defined in Table 5. It will be 
updated by using Equation (1), where b is a parameter that can 
be adjusted depending on the simulation (as shown in Section 
VI). Patients will leave the system if (i) the Karnofsky score 
turns to 100 (full recovery) or 0 (death), (ii) there is a serious 
incident in a session (patient is transferred to an acute care 
unit), or (iii) the treatment is finished (protocol complete and 
no new protocol). If the Karnofsky score decreases drastically, 
medical activities in the health-care session will be lengthened 
(patient in a bad condition). The length of sessions is updated 
with and adjustment time inversely proportional to the 
Karnofsky score as shown in Equation (2). 
 
TABLE 5 
 
  (1) 
 
    (2) 
 
In addition, the following assumptions are proposed to stick to 
the reality: 
1. Transportation of patients from home to hospital will 
be reported to insurance for reimbursement. 
2. Delivery services of medicines at home have infinite 
capacity. 
3. Processes inside the pharmacy do not have an impact 
on the overall cost of system, so it can be neglected 
in the process modeling. 
Process modeling using Petri nets 
 
Petri Nets (PNs) provide a logical representation of the 
simulation, readers are referred to (Proth & Xie 1995) for 
introduction and presentation of Petri Nets theory. Figure 1 
presents the Petri net modeling of a generic multisession 
treatment, composed of four main processes: (i) setup 
treatment (sub-net SN1), (ii) control session (sub-net SN2), 
(iii) setup session (sub-net SN3), and (iv) the session itself, 
that can occur at home (sub-net SN4) or at the hospital (sub-
net SN5). 
A multi-session treatment is characterized by the repetition of 
an unchanged health-care session. The process starts with the 
definition of treatment (i.e. main medicine, number of sessions 
and place of session). Before each session, a control is 
performed to establish if patient's health status allows the 
session to continue as planned. Results from this control can 
trigger a consultation with a specialist where the treatment will 
be redefined. Finally, the session is realized as planned in the 
treatment. 
 
[FIGURE 1] 
 
Resources: Four resources are considered in this example: (i) 
Nurse (Pr3), (ii) Specialist (in case of chemotherapy is 
oncologist, Pr1 in the petri net model), (iii) Coordination nurse 
(Pr2) and (iv) Hospital Beds (Pr5). Some coordination 
activities require a medical expertise, like receiving 
information from patients and the coordination activities in the 
setup of the session. These activities are performed by 
coordination nurses while the medical activities are performed 
by nurses. 
 
Processes: Setup treatment process starts when a patient 
arrives to the system. If a patient enters the system when it is 
closed, he will wait until next day (but this time will not be 
counted in the waiting time). Since some patients have to 
come back after sessions, it is difficult to manage daily 
arrivals in both structures separately. The entity (patients) flow 
through model is the following: patients arrive to hospital [T0] 
where treatment is defined by specialists and coordination 
nurses. After registration [T1] the patient enters in the 
consultation [T2] with the oncologist [Pr1] where the 
treatment will be defined. Then, a coordination nurse [Pr2] 
will gather the relevant information [T3] and a nurse [Pr3] will 
evaluate the parameters and apply the selection rule [T4]. This 
selection rule is used to decide if a patient can apply to home-
based treatment or not. Since this decision can drastically 
change the performance of the system, different scenarios will 
be tested during the simulation. The following transition 
correspond to coordination activities such as ensure human 
resources for treatment (assign a responsible or contact the 
free-lance nurse), ensure material for treatment and ensure 
support medicaments [T5], all performed by a coordination 
nurse [Pr2]. After transition [T4], the process of control 
session begins. Orders of biologic samples will be sent [T6] 
and two different paths can be taken. If patient’s Karnofsky 
score is below a certain value of parameter “Karnofsky limit to 
send a nurse to take biologic samples” a freelance nurse will 
be sent at home to take the samples [T7], otherwise it is 
assumed that patient will do the necessary to procure biologic 
samples results from a laboratory [T8]. Depending on the 
results of the biologic samples analysis, the authorization of 
the session [T9] is given by the specialist [Pr1]. If results of 
this analysis are bad, a consultation [T10] with this specialist 
[Pr1] is triggered. These two decisions are controlled by 
parameters “green light percentage” and “Sessions cancelled 
after consultation”. Otherwise the process continues. 
If the session is authorized, the process of setup session is 
triggered. This process starts with three activities of setup, 
similar to the ones done already for treatment: Ensure the 
human resource for the session, ensure materials for the 
session and ensure the session medicines (in the case of 
chemotherapy, send the chemotherapy order to pharmacy) 
[T11]. These three activities are performed by the coordination 
nurse [Pr2]. The session can be held at home or at hospital. 
Session at home (sub-net 4) begins with the activity of 
installing patient in bed and performing some control 
  
operations (such as controlling patient’s blood pressure and 
temperature) [T12]. Then equipment is installed [T13] and the 
free-lance nurse [Pr4] waits until the end of session [T14] or 
until an incident occurs. In order to simplify the model we 
assume that incident arrive only at the end of session time. 
Since both structures are equivalent from the bio-medical 
output standpoint, this probability is the same. A real-life 
example can be found for ambulatory chemotherapy in 
(Buthion et al. 2010), where authors analyzed historical data 
and found probability close to 0.018%,. In case of incident, 
patient must be transported to hospital and will exit the 
process [e1], otherwise start over the control session process 
[T22].  
If session is held at hospital; activities can differ. Patient must 
register [T15] and wait until a bed [Pr5] is free to be installed 
[T16] by a nurse [Pr3]. Control operations and the install of 
patient are done [T17]. A difference with session at home is 
that while patient is waiting for the session to finish [T18], the 
nurse is idle to perform other operations. When session time is 
past, the nurse [Pr3] finish the session (uninstall patient, 
cleaning material, update patient’s file and so on) [t19]. If an 
incident occurs, patient exits the simulation [e2] otherwise the 
process of control session (for the next one) is triggered [T21]. 
 
In the following section, we describe the data collection 
performed during a field observation in order to provide 
relevant inputs to the simulation model. 
 
V. DATA COLLECTION  
 
Data was gathered during three weeks of field-observation in a 
HAH coordination network and in an outpatient service of a 
hospital in Lyon (France). The observation was focused on 
modeling the process including relevant resources, activities 
and interactions between them. At hospital the process is 
performed in two units: (i) a coordination unit, where 
treatment is defined and consultations were held; and (ii) an 
outpatient unit for the session itself. The coordination unit is 
composed of specialist and coordination nurses while the 
outpatient unit of the hospital is composed of beds and nurses. 
Pharmacy related process is not taken into account in this 
work, because they have the same behavior at hospital and 
home-based treatments for the most part.  
The HAH structure shares the coordination unit with the 
hospital but healthcare services are delivered differently: 
coordination nurses contact free-standing nurses to perform 
sessions at home. These free-standing nurses are an abundant 
resource, especially in urban zones. In case of an accident at 
home, the patient is transported to the hospital by ambulance. 
Costs of treatments are calculated taking as an example the 
ambulatory chemotherapy in France. Obviously, these 
parameters must be adapted depending on the pathology and 
the country. Costs are calculated from the insurance point of 
view. At hospital, the price paid by insurance is the sum of: (i) 
price for staying in the structure, (ii) price of medicine and 
(iii) transportation of the patient. Current price for staying at 
hospital is 379.14 €. Price of patient transportation  is equal to 
11.48 € + 0.83 €/Km. 
Cost of session at home-based structure has a fixed part and a 
variable part. Fixed part is the sum of 101.01 € for 
coordination activities, and 23 € for authorization of the 
doctor. Variable part is the working time of liberal nurse: 
47.25 € if the session length is less than 1h30, and 31.5€ + 
18.5€/h otherwise. Cost of medicine delivery is 0.7 €/Km. 
Due to difficulty of gathering real data (Santibanez et al. 
2009) some parameters in the model must be calibrated. To do 
so, a sensitivity analysis is required as presented in Section VI. 
These special parameters are the (i) the Karnofsky threshold to 
send a nurse to do the control visit, (take the biologic sample 
in the example) that is set to 40, (ii) the health factor 
adjustment (5 min) for changing operations time and (iii) the 
Karnofsky score change after a session (initially set at 5 
Karnofsky units). 
Finally, required parameters for the simulation model are 
listed below. These parameters are used to define simulation 
scenarios. 
1. Structure selection rule: this rule is used to send a patient 
to a home-based treatment or not. Four different rules are 
tested: (i) when a desired bed load at hospital is reached, 
the following patients will be sent to the home-based 
structure; (ii) using a certain percentage threshold (for 
example 50% of patients are sent to each one); (iii) based 
on the approved list of medicines. Some legislation 
forbids delivering some medicines at home. This means 
that all possible medicines will be delivered at home. (iv) 
healthy patients will be kept at hospital. Since insurance 
will pay an average price for treatment, patients 
consuming fewer resources (in a good health status) will 
be sent to the structure with higher marginal costs. 
 Resource amounts: number of beds at hospital, nurses, 
coordination nurses and oncologists.
In the following key elements of the simulation model such as 
parameters, key performance indicators and simulation 
elements are presented in the following section.  
 
VI. SIMULATION 
Model validation and sensivity analysis 
 
A sensitivity analysis of the hypotheses is proposed in order to 
know their impact on costs, thus eliminate the bias in the 
comparisons. Hypotheses in the model are modeled using 
variables (Karnofsky limit to send nurse to take biologic 
samples, adjustment health factor, Karnofsky change after 
session, green light percentage, and percentage of cancelled 
sessions after consultation). Table 6 presents the impacts of 
the hypotheses as a percentage of costs for the insurance. 
 
TABLE 6 
 
  
The model was validated by tracking a group of patients 
through the simulation in various scenarios, including extreme 
cases (increase of demand), in order to prove that logic behind 
the model is valid. The model was extensively discussed with 
health-care professionals and practitioners of a territorial 
network of healthcare (an example of a home-based structure 
treated in this article). As presented in Table 6, results are not 
sensible to most of the hypothesis. The most sensible 
parameters are the change of the Karnofsky score after the 
health-care session and the percentage of canceled sessions 
after consultation. These two parameters were set by trial-and-
error until the total number of sessions in the simulation was 
close to reality. 
 
Simulation results 
 
Various experiments are provided to show how results on 
economic comparisons can change depending on the 
parameters of system. The first important question to study is 
patient triage: which patients should leave hospital to be 
treated at home? In reality this decision is taken by the doctor 
responsible of treatment and the patient. However, it is 
difficult to model such decision because various types of 
parameters (social, medical, affective) are taken into account. 
In this first experiment, we model the decision using four 
different selection rules, based on: (i) a certain percentage of 
patients, (ii) the occupancy level of outpatient unit, (iii) the 
approved list of medicines (French legislation forbids to give 
home-based treatments for some medicines) and (iv) the 
health condition of patients. 
Required number of replications to ensure a confidence of 
95% for different measures was 25 (Kelton & Law 2000). 
These experiments were performed using 1,000 patients 
arriving in the system with an inter-arrival time following an 
exponential distribution with a mean of 40 minutes. In order to 
compare results, a base scenario is simulated. The simulation 
horizon is 200 days. Hospital is open 10 hours per day; 
however, if resources are busy after closing time, they must 
finish their actual task (overtime). This is why reported 
resource utilization may exceed 100%. 
Different hospital configurations were tested by changing the 
number of available resources (beds, nurses, coordination 
nurses and oncologists). 10 different configurations constitute 
the experiments, presented in Table 7. In the base selection 
rule (BSR), all patients are treated at hospital The index of the 
scenario is given in the first column; the scenario code a.b.c.d 
stands for: a number of beds, b number of nurses, c number of 
coordination nurses and d number of specialists at hospital. 
The table presents the total cost for the insurance, the average 
percentage of utilization for every resource and the number of 
protocols and sessions. Relevant performance indicators are 
the different costs for the insurance and the resource 
utilization for the hospital. In the following, several selection 
rules will be tested and compared with the «normal» behavior 
of the hospital. 
 In Table 8 and Table 9 the mean values (of different 
configurations) of key performance indicators for each 
selection rule (SR) are presented. Scenario number 1 of the 
BSR in Table 7 was used as base scenario tables 8 and 9. In 
Table 9, columns two to four presents the occupation rate of 
the respective resource and column six present the average 
waiting time in minutes.  
 
TABLE 8 
 
TABLE 9 
 
Several facts are shown in these results. For example the 
changes in resource consumption show us how opening of a 
home-based structure will change the assignments of resources 
at the hospital. Bed utilization can be highly reduced (around 
55% in pools selection rule) showing how HAH can be used to 
control both the flow of patients and the consumption of 
resources at hospital. Obviously, such decrease in bed 
utilization is counter-balanced by an increase in the utilization 
of coordination nurses (around 22% in the same SR). This is 
important because, even if it is not in within the scope of the 
study, there will also be an increase use of free-standing 
resources. In this study we suppose that regions where patients 
live have enough free-standing resources to undertake the 
demand hospitals will not accept (which is the case in the 
Lyon region). However, there can be a leak of free-standing 
resources in low populated territories or high standing cities 
making the development of HAH difficult.  
The main difference between SR(i) and SR(ii) lies in the fact 
that in SR(i), specialists must only know the percentage of the 
patients that he has already sent in each structure without 
taking into account levels of activities. In SR(ii), specialists 
must know the current level of activity of the fixed and home-
based structures. Such results compound with the findings of 
(Armstrong et al. 2008), where authors showed that a lack of 
“pressure” on oncologist was the main explanation of a low 
activity level in the home-based structures.  
In France, legislation forbids the delivery of certain types of 
chemotherapy at home. This type of decision can be adapted 
to the multi-session treatment studied in this article. Every 
year a new list of authorized chemotherapy molecules is 
available. SR(iii) delivers the treatment at home every time 
that the specialist has prescribed an authorized medicine, 
otherwise the patient will be treated at the hospital. The results 
of SR(iii) are similar to SR(ii). These results are highly 
dependent on the probability of choosing authorized 
treatments. In this case specialists are critical actors since they 
will define the behavior of the system.  
Another important issue that can affect the results on 
economic comparisons is the cost of free-standing resources. 
This cost change often in reality. In some low density regions 
or high standing cities, free-standing resources are expensive. 
In other regions they can refuse to deliver high technical care, 
leading to the need of using additional and costly resources. 
Economic comparisons cannot neglect the possible change in 
free-standing costs. 
 
Discussion 
  
 
It may be difficult to control the patient flow at hospital using 
only one selection rule. In reality, decision makers will use a 
mix of selection rules depending on features of the structures, 
nature of the territory and other information. If decision 
makers are interested in marginal costs, they might prefer 
the pool selection rule since it gives priority to structure that 
have expensive fixed costs. To the contrary, if decision 
makers are concerned about coverage of hospital, they 
may choose one based on authorized medicines and 
encourage sending patients to HAH, leaving space at 
hospital for other types of treatments. It is difficult to give a 
“golden rule” for selection of treatment location. 
Results on economic comparisons can change if parameters of 
the system change. Discrete-event simulation is a powerful 
tool to overcome these changes giving the decision maker the 
opportunity to test different scenarios before taking decisions. 
Introduction of health status and geographical distribution of 
patients in the simulation let us know the importance to treat 
the question about the economic pertinence by specific 
scenarios and avoiding universal conclusions. These aid-
decision tool can be used to explore different possibilities 
about the system (concurrent hospitals, urban-rural 
geographical distributions) about the treatments (changes in 
incident probabilities and operational times) and about the 
structures (available resources, resources schedules and 
capacities). 
 
 
VII. CONCLUSION AND PERSPECTIVES 
Economic comparisons of structures are difficult to make 
because of various aspects involving the stability of 
conclusions and results in time. One of the main reasons is the 
difficulty to make a neutral comparison taking into account the 
original purpose of structure and environmental conditions. In 
order to overcome these difficulties an approach that takes into 
account both health status of the patient and demographic 
information was proposed. This approach lets us compare and 
study different structures for delivering a multi-session 
treatment at hospital and/or at home. Four selection rules have 
been tested in order to study the possible behavior of the 
system when offering home based services and its impacts 
inside hospitals.  
It is important to consider also the role of specialists, even if a 
coordination cell exists to decide the location of treatments: 
specialists can prescribe a medicine that is not included in the 
authorization list and patient will not even be considered for a 
HAH. A lack of ”pressure” or motivation to send patient to 
HAH structures can be an important factor of the economic 
failure of these structures (even if their utilization would result 
in a better global economic performance). This is why it is 
very important to give them high quality information about the 
actual state of the hospital (level of activity, use of critical 
resources and economic strategies) at the right time. 
 
As it can be seen, HAHS can be used to control and improve 
patients flow on hospitals. Decisions about offering a multi-
session treatment at home must be taken, not only because of 
economic impacts on hospitals, but also because it follows 
strategic goals of the organization. This decision must be 
issued following a strategic analysis. Some important 
questions are: How newly available beds should be used in the 
hospital? Which territories will be covered? What is the best 
logistic strategy for delivering the medicines? 
The next step of this study consists in introducing more 
elements of decision like the localization of the hospital (rural 
or urban), potential new treatments at hospital, professionals 
skills and additional activities like routes planning. New 
selection rules may be designed to take into account 
information about geographical position of patients of 
patients, or economic status of hospitals. Another perspective 
may lead us to consider pharmacy activities and liberal nurses 
conditions (capacity and probabilities to refuse some patients). 
These activities can be critical in other HAHS. 
Finally, it may be interesting to introduce elements regarding 
production and distribution of medicines. Some important 
question that may be studied in the following are: Which is the 
impact of the pharmacy operations in economic performance 
of structures? Which is the impact of geographical distribution 
of these pharmacies? What are the impacts inside structures 
caused by changes in geographical distribution? 
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